11:49:00 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-04-25 Årsstämma 2025
2025-02-26 Bokslutskommuniké 2024
2024-10-24 Kvartalsrapport 2024-Q3
2024-07-18 Kvartalsrapport 2024-Q2
2024-04-26 Ordinarie utdelning MAGLE 0.00 SEK
2024-04-25 Årsstämma 2024
2024-04-18 Kvartalsrapport 2024-Q1
2024-02-16 Bokslutskommuniké 2023
2023-10-25 Kvartalsrapport 2023-Q3
2023-07-18 Kvartalsrapport 2023-Q2
2023-04-27 Ordinarie utdelning MAGLE 0.00 SEK
2023-04-26 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-11-09 Kvartalsrapport 2022-Q3
2022-08-17 Kvartalsrapport 2022-Q2
2022-05-19 Ordinarie utdelning MAGLE 0.00 SEK
2022-05-17 Årsstämma 2022
2022-05-05 Kvartalsrapport 2022-Q1
2022-02-25 Bokslutskommuniké 2021
2021-12-14 Extra Bolagsstämma 2021
2021-11-16 Kvartalsrapport 2021-Q3
2021-08-17 Kvartalsrapport 2021-Q2
2021-05-14 Kvartalsrapport 2021-Q1
2021-05-03 Ordinarie utdelning MAGLE 0.00 SEK
2021-04-18 Årsstämma 2021
2021-02-25 Bokslutskommuniké 2020
2020-11-27 Extra Bolagsstämma 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-07-14 Kvartalsrapport 2020-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Magle Chemoswed är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom utveckling av analytiska program. Produktportföljen är bred och inkluderar exempelvis program för intern uppföljning, process- samt systemhantering. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster inom arbetsområdet. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Magle Chemoswed har sitt huvudkontor i Malmö.
2022-05-17 13:00:00

Today, on May 17, 2022, the annual general meeting was held in Magle Chemoswed Holding AB (publ) by way of advance voting (postal vote) in accordance with temporary legislation.

A summary of the adopted resolutions follows below:

  • Adoption of the Income Statement and Balance Sheet

The AGM resolved, in accordance with the Board of Director’s proposal, to adopt the income statement and the consolidated income statement, as well as the balance sheet and the consolidated balance sheet, as set out in the annual report 2021.

  • Allocation of Profits

The AGM resolved, to appropriate the company’s results according to the Board’s proposal in the annual report. The AGM also resolved, in accordance with the Board’s proposal, that no dividend be paid for 2021.

  • Discharge from Liability

The AGM resolved, in accordance with the Board’s proposal supported by the auditor, to discharge the members of the Board of Directors and the CEO, respectively, from liability in respect of their management of the Company’s business during the financial year 2021.

  • Election of the Board Members, Auditor, Fees to the Directors and Auditor

The AGM resolved, in accordance with the proposal, that the number of Directors appointed by the general meeting shall remain the same, i.e. the Board of Directors shall consist of six (6) directors and one deputy director appointed by the general meeting. The AGM resolved in accordance with the proposal to re-elect Hans Henrik Lidgard, Martin Lidgard, Malin Malmsjö, Sven-Christer Nilsson, Mats Pettersson and Joel Eklund as ordinary members of the Board and to re-elect Julia Kamber as a deputy member of the Board. It was further resolved to re-elect Hans Henrik Lidgard as chairman of the Board of Directors. All elections are for the period until the end of the next annual general meeting.

It was resolved to elect Ernst & Young AB with authorized auditor Henrik Rosengren, as the auditor of the Company until the end of General Meeting 2023.

The AGM resolved in accordance with the proposal that remuneration for the Board Members appointed by the shareholders' meeting that are not employed by the group shall amount to 100 000 SEK and for the deputy member - 50 000 SEK for the time until the end of the next annual shareholders' meeting, whereof the chairman of the Board shall receive 200 000 SEK. The committee members shall receive 25 000 SEK.

The AGM resolved as proposed that the remuneration to the auditor shall be in accordance with the approved rates.

  • Authorisation for the Board to issue new shares

The meeting resolved to authorise the Board to issue new shares, with or without pre-emption rights for the shareholders. The total number of shares that may be issued by virtue of the authorisation must be within the limits of the share capital according to the articles of association. The total number of shares that may be issued by virtue of the authorisation may not exceed 10 per cent (%) of the total number of the shares in the Company at the time when the Board first utilizes the authorisation.